What is FOLD's P/E ratio?

AMICUS THERAPEUTICS INC (FOLD) currently trades at a P/E ratio of 239.79.

AMICUS THERAPEUTICS INC reports a Return on Equity (ROE) of -9.89%.

What is FOLD's dividend yield?

AMICUS THERAPEUTICS INC offers a dividend yield of 0.00%.

What is FOLD's Deepscope Quality Score?

Deepscope rates FOLD's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy FOLD?

Deepscope's AI Timing Score for FOLD is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does FOLD belong to?

AMICUS THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu FOLD (NASDAQ) | AMICUS THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-04-24 | FS: 2025-12-31)

FOLD

AMICUS THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 95

USD 14.49

0.03 (0.21%) Day Change

Watchlist Portfolio Compare Chart

239.79

P/E

1.46

D/E

-9.9%

ROE

-2.9%

ROA

0.00%

Div Yield

-4.73

PEG

AMICUS THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 14.49 Price 0.03 (0.21%) Day Change	NEWS SCORE: 95

FOLD Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

41%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	95
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	14.49
PBV / Sector	16.61 / 4.63
Earning Per Share	-0.09

PE / Sector	239.79 / 17.43
PEG or PE/Growth / Sector	-4.73 / 0.53
Average 1M Daily Value	37.07 M GREAT
Average 1W Daily Value	36.23 M GREAT

Yếu tố Kỹ thuật

100%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

39%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4.27 / 449.48
NPM Average (%) / Sector	-31.18 / -1,506.49
NPM Change Average (%) / Sector	-59.65 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-2.85 / 30.58
ROA Average (%) / Sector	-15.54 / -347.17
ROA Change Average (%) / Sector	-54.58 / 5,125.52
ROE (%) / Sector	-9.89 / -3.58
ROE Average (%) / Sector	-81.42 / 40.65
ROE Change Average (%) / Sector	-62.01 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Chi tiết đăng ký

Analyze Date	2026-06-06 09:09:25
Symbol	FOLD
Name	AMICUS THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	314.00 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	4,555.01 / 8,857.28

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 47 Hulfish Street, Princeton, NJ, United States, 08542

Phone: 609 662 2000

Website: https://amicusrx.com

Employees: 511

Sector: Healthcare >> Biotechnology

Description: Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease; and DMX-200, a small molecule inhibitor of the chemokine receptor 2 that is in a pivotal Phase 3 study for the treatment of focal segmental glomerulosclerosis (FSGS) kidney disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold; and Dimerix Limited for the commercialization of DMX-200 for the treatment of FSGS and other indications. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey. As of April 27, 2026, Amicus Therapeutics, Inc. operates as a subsidiary of BioMarin Pharmaceutical Inc.